When MM, CLL and WM were evaluated as a single group in comparison with the healthy control group, we found a significant association between the linked HAS1 intron3 SNPs, and the risk of systemic B-cell malignancy. This evidence concerns the gene HAS1 and B-cell chronic lymphocytic leukemia.